Prof. Chaohong He 何朝宏
Chief Physician, Professor
Department of Urology, Henan Cancer Hospital, Zhengzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of adrenal, kidney, ureteral, bladder, prostate, and male genital tumors using minimally invasive urologic techniques.
Dr. He is Chief Physician, Professor, and Director of Urology at Henan Cancer Hospital, with a medical doctorate. With 31 years of experience in clinical practice, teaching, and research, Dr. He has conducted international exchanges in the US, UK, France, South Korea, Singapore, Hong Kong, and Japan. Dr. He has led multiple provincial and national research projects and received two provincial science and technology progress awards.
Professional roles
- Member, Urological and Male Genital Tumor Professional Committee, China Anti-Cancer Association
- Vice Chair, Urology Branch, Henan Medical Association
- Vice President, Urologist Branch, Henan Medical Doctor Association
Name order: in Chinese the family name comes first (He Chaohong). Papers usually list the name as Chaohong He or He C.
Selected publications
15 papers on PubMed matched by name and affiliation; 4 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cell Death Discov, 2024 (senior author): An oncogenic role of lncRNA SNHG1 promotes ATG7 expression and autophagy involving tumor progression and sunitinib resistance of Renal Cell Carcinoma. PubMed 38851811
- Biochem Genet, 2024 (senior author): Cancer-Associated Fibroblasts Boost Tumorigenesis of Clear Cell Renal Cell Carcinoma via Exosome-Mediated Paracrine SNHG1. PubMed 37815626
- Exp Cell Res, 2021 (senior author): HMMR is a downstream target of FOXM1 in enhancing proliferation and partial epithelial-to-mesenchymal transition of bladder cancer cells. PubMed 34624323
- Biomed Pharmacother, 2019 (senior author): Systematic screening of protein-coding gene expression identified HMMR as a potential independent indicator of unfavorable survival in patients with papillary muscle-invasive bladder cancer. PubMed 31568988
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion